I am a consultant respiratory physician at Spire Leeds Hospital.

I have been a consultant respiratory physician and honorary senior lecturer at Bradford Teaching Hospitals NHS Foundation Trust since 2014. I have also been Director of the National NIHR Patient Recruitment Centre, Bradford since June 2020. In addition, I am a Visiting Honorary Professor at the Academic and Life Science Department at the University of Bradford. I lead the severe asthma service at Bradford Teaching Hospitals NHS Foundation Trust. The centre is one of the centres in Yorkshire and Humber, which can initiate biologics in severe asthma. I am also the National Clinical Lead for Industry for the Respiratory Disorders Speciality Group, NIHR and Strategic Clinical Lead for Industry at the Yorkshire and Humber Clinical Research Network.

I lead the Respiratory Clinical Trials unit at BIHR. This unit has grown to become one of the largest self-funded respiratory clinical trials in the UK. The unit is one of the top five most reliable and experienced severe asthma clinical research units in the UK. Since 2012 I have been the chief co-ordinating investigator in the UK for several multi-national phase 2 and 3 severe asthma and COPD trials. The Unit has recruited several global and European first patients into these trials. The unit attracts patients for its clinical trials programme from across the Yorkshire region. The unit has well-established links with all major pharmaceutical companies as well as major clinical trials organisations.

I have a particular interest in inhalation profiles in patients with severe asthma and COPD and have published my work in this field. This work culminated in the Bradford Institute of Health Research becoming one of five National NIHR Patient Recruitment Centres in June 2020. The unit has links with the Universities of Southampton, Nottingham and Huddersfield.

In 2015 and 2016 I was awarded the Best Principal Investigator award for the UK for my delivery into the commercial respiratory research portfolio by NIHR. I have also been the Associate Director of Research at the Bradford Institute for Health Research since 2014. Since my appointment I have been able to grow the commercial research portfolio at the BIHR to over 1.25 million pounds annually. The unit has now moved to a brand new facility under my stewardship and has enhanced research in several new areas in the Trust.

I set up the severe asthma service in Bradford Teaching Hospitals NHS Foundation Trust in 2006 and have published several of my research works on severe asthma. I run a weekly severe asthma clinic at Bradford Teaching Hospitals NHS Foundation Trust and chair a severe asthma MDT held fortnightly at the BIHR. I am an active senior member of the wider Yorkshire Severe Asthma Network.

I have a particular interest in inhalation profiles in patients with severe asthma and COPD and have published my work in this field. I have pioneered the use of Omalizumab in the treatment of severe allergic asthma and have been involved in most clinical trials involving the newer biologic treatment in severe asthma. In 2016, I was the leading investigator in the APEX 2 study, which was the largest real life study in the UK on the real life effectiveness of Omalizumab in the treatment of severe allergic asthma.

In October 2019 I was awarded the NIHR/RCP Award for research in the consultants’ category. I was also awarded the University Annual Teaching Award for Medical Students in 2012.

I am considered an International Key Opinion Leader in the design and conduct of multi-national severe asthma COPD clinical trials. My efforts into these clinical trials have played a major part in the UK licence of these products.